Ask Deandra: Can I Get a DWI in Texas if I’m Only on Prescription Medication?

Here is the longer answer: what the statute actually covers, which medications drive most prescription DWI prosecutions, why “as prescribed” is not a magic shield, how a forensic defense addresses these cases, and what can be done about the record afterward.

The Statute Does Not Care That the Drug Was Prescribed

The text of Texas Penal Code §49.01(2)(A) does not distinguish between illegal drugs, lawful drugs, prescribed medications, or over-the-counter products. The statute reaches “any other substance” introduced into the body that causes loss of normal mental or physical faculties.

The authority for that is a statute, not a line of cases, and it is worth naming precisely. Penal Code §49.10 provides that in a prosecution for DWI and the other intoxication offenses, the fact that the defendant is or has been entitled to use the alcohol, controlled substance, drug, dangerous drug, or other substance is not a defense. That one sentence is why “my doctor prescribed it” does not end the case. A prescription is a complete answer to a charge of possessing a drug without authorization. It is not an answer to the allegation that the drug caused you to lose the normal use of your faculties behind the wheel.

The Court of Criminal Appeals has applied that framework to a prescription case and affirmed the conviction. In Farmer v. State in 2013, a driver whose wife had laid out his pills took Ambien by mistake, along with Ultram and Soma. The court held that the mistake did not matter, because the voluntary act the statute requires is picking up and swallowing the medication. That case is discussed in more detail below, because it is also where the limits of the “nobody warned me” argument are drawn.

The legal theory is straightforward, even if the result feels counterintuitive. Texas DWI law is built around the public-safety principle that an impaired driver on the road is a danger regardless of the source of the impairment. A driver impaired by Ambien is not less dangerous than a driver impaired by alcohol and, from the State’s perspective, both should face the same criminal exposure. Whether you agree with that policy or not, it is the law you are working with.

The result is that a sympathetic defendant, a senior citizen taking medications prescribed by a trusted physician for legitimate medical conditions, can find herself charged with the same offense as a drunk driver. The cases are real and they happen across Texas every week.

The Medications That Drive Most Prescription DWI Cases

Several categories of prescription medication appear repeatedly in Texas prescription DWI prosecutions. None of these is automatically disqualifying for driving. Millions of people take these medications and drive safely every day. But each has documented effects on cognition, reaction time, or motor function that the State will use to argue impairment:

• Sleep aids (zolpidem, eszopiclone, zaleplon). Brand names include Ambien, Lunesta, and Sonata. In 2013 the FDA required lower bedtime doses of zolpidem for women, cutting the immediate-release dose from 10 mg to 5 mg and the extended-release dose from 12.5 mg to 6.25 mg, because zolpidem is cleared more slowly in women and morning blood levels can be high enough to impair driving. In April 2019 the FDA went further and added a boxed warning, its strongest, to all three drugs for complex sleep behaviors including sleep-driving, and made a prior episode an outright contraindication. Sleep driving, meaning driving with no conscious memory of the trip, is not folklore. It is a labeled adverse effect.
• Benzodiazepines (alprazolam, diazepam, lorazepam, clonazepam). Brand names include Xanax, Valium, Ativan, and Klonopin. Prescribed for anxiety, panic disorder, insomnia, and seizures. Side effects include drowsiness, impaired coordination, slowed reaction time, and cognitive effects that can be amplified by even small amounts of alcohol. One point worth knowing before you see your own lab report: diazepam breaks down into nordiazepam, temazepam and oxazepam, all of which are themselves prescription benzodiazepines. A toxicology report listing four benzodiazepines does not mean four prescriptions, and prosecutors have been known to read it that way.
• Opioid pain medications (hydrocodone, oxycodone, codeine, tramadol). Brand names include Vicodin, Norco, OxyContin, Percocet, and Ultram. Side effects include sedation, slowed reaction time, and impaired judgment. Combined with alcohol or benzodiazepines, the impairment can be substantial. Codeine also converts to morphine in the body, so a patient taking prescribed codeine produces a positive morphine result.
• Muscle relaxers (cyclobenzaprine, carisoprodol, methocarbamol). Brand names include Flexeril, Soma, and Robaxin. Frequently prescribed after injuries, back surgery, or for chronic muscle conditions. Two forensic quirks matter here. Carisoprodol metabolizes to meprobamate, which is itself a sedative with a half-life roughly five times longer than the parent drug, so a Soma case arrives with two analytes and a timeline that is not obvious from either one alone. And cyclobenzaprine is structurally close to the tricyclic antidepressants, close enough that it has been misidentified as amitriptyline on immunoassay screening.
• Antihistamines (diphenhydramine, hydroxyzine). Both prescription and over-the-counter. Often used as sleep aids or for anxiety. The sedation is significant and it is well studied. In a driving-simulator trial published in the Annals of Internal Medicine in 2000, diphenhydramine impaired driving performance more than alcohol did, though the subjects there were between 25 and 44 rather than elderly. The American Geriatrics Society Beers Criteria tell physicians to avoid first-generation antihistamines in older adults outright, because clearance is reduced with age and the anticholinergic effects are strong.
• Antidepressants and antipsychotics. Some classes carry warnings about driving and operating heavy machinery, particularly during dose changes.
• ADHD medications. Both stimulant and non-stimulant ADHD medications can affect cognition and behavior in ways the State may argue produced impairment.

Texas’s Compassionate Use Program permits low-THC cannabis under specific conditions, and the program was substantially expanded in 2025. Patients enrolled in it are still subject to DWI prosecution under §49.04 if the medication produced loss of faculties at the time of driving. The prescription does not change the analysis under the loss-of-faculties prong.

This list is illustrative, not exhaustive. The point is that prescription DWI is not an exotic charge. It reaches across the most commonly prescribed drug classes in American medicine. And the same caution applies to every entry on it: the presence of any of these substances in the blood does not prove intoxication. The State must prove that the person charged did not have the normal use of their mental or physical faculties because of that substance.

“As Prescribed” Is Not a Defense But It Matters

Many defendants assume that if they took the medication exactly as prescribed by a licensed physician, they cannot be charged with DWI. That assumption is wrong. The State does not have to prove misuse. The State has to prove loss of faculties, and a properly prescribed drug, taken at a properly prescribed dose, can still cause loss of faculties under the right conditions.

That said, “as prescribed” is not legally meaningless. It is part of the defense narrative in several ways:

• Medical context for the jury. Even when no formal defense is available, the fact that the medication was prescribed for a legitimate medical condition, taken at a prescribed dose, and consumed without warning of impairment is part of the story the jury hears. It does not eliminate criminal exposure, but it changes the moral framing of the case.
• Mitigation at sentencing. If a case proceeds to a punishment phase, prescription medication context matters. Judges and juries sentence prescription DWI defendants differently than they sentence repeat alcohol offenders.

The realistic message: a prescription does not exempt you from DWI prosecution, but it can shape every part of how the case is defended, negotiated, and ultimately resolved.

Involuntary Intoxication Is Not the Defense. The Involuntary Act Is.

There is a piece of advice about prescription DWI that circulates widely online and is wrong: that if your doctor or pharmacist never warned you the medication could impair driving, you can raise a defense of involuntary intoxication.

Texas courts have rejected that defense in the DWI context. Because DWI requires no culpable mental state, involuntary intoxication is not available, and it does not matter that you never intended to become intoxicated. The Fort Worth court said so directly in Brown v. State in 2009, holding that involuntary intoxication cannot be a defense to DWI because the Legislature did not write a culpable mental state into the offense. Brown is worth understanding for what it is, which is an intermediate appellate decision in which that court departed from its own earlier position.

The Court of Criminal Appeals reached the harder version of the question in Farmer v. State in 2013, and the answer there is the one that governs. Farmer took the wrong pill by mistake. The court held that it made no difference: “It is of no consequence that Appellant mistakenly took the wrong prescription medication when he knew that he was taking a prescription medication and was aware that he was prescribed medications with intoxicating effects.” If you are looking for authority that taking the wrong medication by accident is a defense in Texas, this is the case that says it is not.

There is a related theory that does exist, and it goes by a different name. Penal Code §6.01(a) provides that a person commits an offense only if he voluntarily engages in conduct. Conduct is involuntary only when it is the non-volitional result of someone else’s act, is set in motion by an independent non-human force, is a physical reflex or convulsion, or is the product of unconsciousness, hypnosis or another non-volitional impetus. Texas courts point to automatism, rather than involuntary intoxication, as the correct theory when voluntariness is genuinely at issue. Automatism is conduct occurring without will, purpose, or reasoned intention: sleepwalking, behavior carried out in a state of unconsciousness, or dissociation without full awareness.

Be clear-eyed about how narrow the opening is, because this is where online advice goes wrong. Farmer makes the voluntary act the swallowing of the pill, not the driving, so a driver who knowingly took his own medication has already supplied the voluntary act even if he remembers nothing afterward. Texas courts have also held that amnesia by itself does not raise the issue, and that a claim of involuntary conduct is unavailable where the defendant voluntarily took the intoxicant knowing its effect. And the request to the court has to be framed as voluntariness or automatism rather than involuntary intoxication, or nothing is preserved for appeal.

Where the theory does live is the case where the ingestion itself was not the defendant’s doing. Farmer expressly preserved that: if a third person causes the accused to become intoxicated, by slipping something into a drink or forcing an intoxicant on him, the involuntary conduct defense is available. That is a real and different fact pattern from the one most prescription defendants have.

The practical point for a defendant is this. The fact that nobody warned you is real and it belongs in your case. It belongs there as medical context and as mitigation, not as a defense with a name Texas courts have already turned down.

Older Adults Face a Specific Risk Profile

This post applies to anyone on prescription medication, but it has particular relevance for older adults. Several factors converge to make seniors over-represented in prescription DWI prosecutions:

• Pharmacokinetic changes with age. Liver and kidney clearance declines, and the effect is not uniform across drugs. Oxidative liver metabolism slows considerably with age while conjugation is largely spared, which in practice means alprazolam, diazepam and clonazepam accumulate in an older patient more than lorazepam or oxazepam do. For fat-soluble drugs like the benzodiazepines the more reliable consequence is a longer duration of effect rather than a higher peak, because the drug distributes into a larger volume.
• Increased sensitivity at the same concentration. This is the stronger half of the argument and it is often left out. Older patients are more sensitive to the central nervous system effects of these medications independent of how much is in the blood. Sedation appears at lower doses and at lower plasma concentrations than in a younger patient. That point does not depend on clearance at all, which makes it harder for a State toxicologist to answer with a number.
• Multiple medications from multiple prescribers. Older adults frequently take several prescription medications simultaneously, sometimes prescribed by different doctors who do not coordinate. Interactions can produce sedation or cognitive effects that none of the individual medications would produce alone.
• Underlying medical conditions. Diabetes, low blood sugar, mini-strokes, dehydration, urinary tract infections and other conditions common in older adults can mimic intoxication on field sobriety tests: unsteady balance, confusion, slurred speech, slow movement.
• Reduced reserve capacity. Younger adults often tolerate medication side effects without obvious behavioral changes. Older adults with less physiological reserve may show effects from the same dose that a 35-year-old would not.

Officers are not trained to distinguish medication side effects, drug interactions, or medical conditions from voluntary alcohol intoxication. They observe behavior and make a charging decision. The forensic and medical context that explains the behavior is usually developed only after arrest, by the defense.

How the State Builds a Prescription DWI Case

The framework for proving prescription DWI is the same as any drug-based DWI under Texas law. The State has to establish:

• Operation of a motor vehicle in a public place. Driving on a road or highway, in a parking lot open to the public, or in another public location.
• Loss of normal use of mental or physical faculties. Proven through driving behavior, officer observations, statements, field sobriety test performance, and witness testimony.
• Loss of faculties caused by the introduction of a substance. Proven through chemical evidence, typically blood toxicology, the defendant’s own statements about medication use, prescription bottle contents, or pill counts.

Notice what the State does not have to prove: a quantitative threshold of the medication in the blood. Texas has no per-se drug limit. The State has to prove that the substance was present and that it caused loss of faculties, not that it reached a particular concentration. This both helps and hurts defendants. It hurts because there is no “safe” level the defense can point to. It helps because the State has to do the harder work of connecting presence to impairment, and that connection is forensically contestable.

Forensic Defense in a Prescription DWI Case

Defending a prescription DWI case requires a defense lawyer who can work in the medical and pharmacological literature, not just the statute book. An entire chapter of Deandra Grant’s book, The Texas DWI Manual, published by James Publishing and used by defense lawyers across the state, is devoted to drugged driving defense. The categories of analysis:

• The chemical evidence. Method validation, calibration, lower limits of quantitation, ion suppression, and analyst qualifications are all defensible territory. There is more on this below.
• The pharmacology. Was the concentration measured consistent with therapeutic dosing or with abuse? Was the drug actively present, or was the analyte a metabolite that proves prior use without proving current effect? Was the concentration in a range associated with documented impairment, or below the level at which most patients show observable effects?
• Tolerance. Patients on a stable schedule develop tolerance to the sedating effects of these medications over time. This is measurable rather than theoretical: in on-road testing, patients who had used a hypnotic for three years or more showed no significant driving impairment, though the same research found measurable deficits on some cognitive tasks. Crash risk in the epidemiology is concentrated in the first weeks of a new prescription and falls substantially after that. The State’s theory of impairment often assumes a drug-naive patient, and the prescription history is what shows that assumption is wrong.
• The behavioral evidence. Officers are trained to look for clues that correlate with alcohol intoxication, not medication side effects. The mismatch between how the field sobriety battery was validated and how these drugs actually behave is fertile defense ground, and it is more specific than most people realize. See below.
• The medical context. The defendant’s actual medical conditions, prescription history, treatment plan and drug interactions are all part of the case. Subpoenaed medical records and expert medical testimony often surface information that completely reframes the State’s case.
• The prescribing physician. Your own doctor is a witness. A treating physician can testify about why the medication was prescribed, what effects are expected at your dose, and whether impairment would be anticipated in a patient with your history. That testimony comes from someone who actually knows the patient, which is a different kind of evidence than a State toxicologist reading a number off a report.
• The DRE evaluation, if performed. Drug Recognition Evaluator examinations are observational, not chemical. The twelve-step protocol has documented reliability problems and can be challenged on cross-examination. The criticisms are specific. The protocol leans heavily on the evaluator’s subjective interpretation, evaluators apply it inconsistently, its accuracy in naming a particular drug category is limited, and it assumes that what the officer observes during the evaluation reflects the driver’s condition at the time of driving. That evaluation often happens hours after the stop, which is a long time in the life of a medication.

Generic DWI defense rarely produces good outcomes in prescription cases. The credentials and the analytical literacy required are different.

What to Do if You Take Prescription Medication and Drive

Practical steps to reduce the risk of prescription DWI exposure:

• Talk to your prescribing doctor about driving. Ask specifically about side effects that affect cognition, reaction time, or coordination. Get the answer documented in your medical record.
• Read the medication guide. Pay particular attention to warnings about driving, operating heavy machinery, and combining the medication with alcohol or other drugs.
• Be cautious during dose changes. New prescriptions and dose increases are when adverse effects are most likely, and they are also when the crash-risk data is worst. Avoid driving until you know how a medication affects you.
• Avoid alcohol while taking sedating medications. Even one drink can dramatically amplify sedation and slowed reaction time. In the epidemiology, benzodiazepines combined with alcohol carry several times the crash risk of either alone.
• Use rideshare or alternate transportation when in doubt. If a medication makes you feel even slightly off, do not drive. The cost of a ride is dramatically less than the cost of a DWI arrest.
• Keep medication documentation. Carry current prescription information in case you are ever stopped. The documentation does not eliminate exposure, but it can support your defense.

If You Have Been Charged with Prescription DWI

If you have already been charged, several things matter immediately:

• Do not discuss medication use with police or prosecutors without counsel. Statements about what you took, when, and how much can be locked into the record and used to establish the State’s case. Identification information only, and nothing further until you have a lawyer.
• Preserve medical records. Your prescribing physician, pharmacy, treating specialists and hospital records all become evidence. Make sure your defense team gets full access.
• Do not stop medication without consulting your doctor. Some medications have serious withdrawal or rebound effects. Being charged is not a reason to stop treatment without medical guidance.
• Hire a DWI lawyer with forensic and pharmacological expertise. Prescription DWI cases live or die on the science. Experience matters, and the right credentials matter.
• Address the ALR deadline, and understand which suspension is even available. The 15-day administrative license deadline runs from the date of service of the notice of suspension, and the medication issues do not change that deadline. But in a consent case there may be no suspension at all. The failure-based suspension requires an alcohol concentration of 0.08 or more, so if you gave a specimen and the analysis shows only prescription drugs, the Department of Public Safety has no basis to suspend and will not send a notice. Three caveats. A refusal is different, because refusing a specimen supports a suspension no matter what the substance was. A driver under 21 is different, because any detectable amount of alcohol suspends a minor. And no administrative suspension is not the same as no license consequence, because a conviction carries its own suspension later.

The Most Important Defense Argument: Presence Is Not Impairment

This is the central issue in almost every prescription drug DWI case, and it is the issue the prosecution is most likely to blur. The presence of a prescription drug in a blood specimen does not establish impairment at the time of driving. These are two different questions requiring two different types of evidence, and the State must prove impairment and not just presence.

Every prescription drug has a therapeutic concentration range, meaning the range within which the medication produces its intended clinical effect. What that range does not come with is a line above which a driver is impaired and below which the driver is not. No such line has been established for these medications, which is precisely why Texas has no per-se drug limit.

Be careful how far you push this, because the honest version is stronger than the overstated one. The epidemiology does show elevated crash risk associated with these prescriptions at a population level. The pooled estimates for benzodiazepines run in the range of one and a half to two times baseline, higher for new users, and several times higher again when combined with alcohol. A defense that tells a jury these medications never impair anyone will meet a State expert holding that literature.

The argument that actually wins is narrower and better supported. A population risk ratio is not proof that this driver was impaired at this moment. The relationship between a concentration measured in a blood tube and actual driving performance depends on the specific drug, the patient’s tolerance, the timing of the last dose relative to the draw, and individual pharmacokinetics. Controlled on-road testing has found no significant driving impairment in patients on stable long-term therapy, and the crash-risk signal in the epidemiology sits largely with new users and with people above therapeutic concentrations. The State’s blood test result does not by itself answer the question the jury has to answer.

Deandra Grant’s Master’s Degree in Pharmaceutical Science and Graduate Certificate in Forensic Toxicology apply directly to this analysis. The relationship between drug concentration and behavioral impairment is not a legal argument. It is a pharmacology argument, and it requires training to make effectively.

Field Sobriety Tests and Why They Don’t Transfer

The three standardized field sobriety tests, HGN, Walk and Turn and One Leg Stand, were validated against a single measure: blood alcohol concentration. That is not a characterization, it is what the validation studies say about themselves. The San Diego field validation study states plainly that the only appropriate criterion measure for assessing the accuracy of these tests is BAC, and that measures of impairment are irrelevant to that assessment. No published accuracy rate exists for detecting impairment by a particular prescription medication at a particular dose.

So the precise objection is not that the tests do nothing in a medication case. It is that an officer who testifies to a validated accuracy percentage in a prescription drug case is quoting a number derived entirely from people who had been drinking. In one controlled study of a sedating prescription drug, the overall pass and fail rates did not shift significantly, but the number of scored clues within the individual tests did. That is the kind of nuance the accuracy figures cannot capture.

The eye test deserves separate treatment, because this is where a general objection can backfire. Horizontal gaze nystagmus is not a universal drug indicator, but it is not irrelevant to medications either. Under the drug symptomatology matrix officers are trained on, HGN is expected from central nervous system depressants, which is the category that holds the benzodiazepines, the sleep aids and several muscle relaxers. It is not expected from narcotic analgesics. That cuts both ways, and both cut in a useful direction. In a benzodiazepine case, the presence of nystagmus establishes consistency with a category, not a degree of impairment, and there is no validated relationship between clue counts and concentration the way there is for alcohol. In an opioid-only case, an officer who reports nystagmus has produced a finding his own training says should not be there, and that is worth a careful cross-examination.

None of this makes SFST performance irrelevant. An officer can testify about observed balance and coordination difficulties as evidence of impairment. But the specific accuracy figures from the alcohol studies do not travel, and the scientific foundation is substantially weaker than the presentation usually suggests. Deandra Grant is a trained SFST instructor and challenges this evidence at the protocol and validation level.

Blood Testing: LC-MS/MS and Its Limitations

Blood specimens in prescription drug DWI cases are analyzed using liquid chromatography-tandem mass spectrometry (LC-MS/MS), which can identify and quantify prescription drugs and their metabolites at very low concentrations. The technology is sensitive and specific. What it is not is an impairment test. LC-MS/MS answers what was in the blood and how much. It says nothing at all about whether the driver had lost the normal use of his faculties, and no amount of analytical precision changes that.

The defense examines the complete data package rather than the summary report. What is genuinely contestable:

• The identification itself. Forensic toxicology standards set criteria for when a compound can be called identified, including a separation technique and a concurrently analyzed reference standard. Whether the laboratory met them is a question with a documented answer.
• Ion suppression and enhancement. Matrix effects are not a vague complaint. The applicable method-validation standard sets a numeric threshold for how much suppression or enhancement is acceptable before the laboratory must evaluate its effect on the result. That threshold is discoverable and testable.
• Calibration, internal standards and quality control. The calibration range and whether the reported result falls inside it; the labeled internal standards used and whether they themselves introduce interference; and the quality control samples run alongside your specimen.
• Measurement uncertainty. A concentration reported as a single number without an uncertainty budget is an incomplete result. This matters most where the value sits near any threshold the State wants to argue from.
• Accreditation and scope. Whether the laboratory is accredited is one question. Whether the specific analyte in your case falls within its accredited scope, and whether its testing scope and cutoffs meet the applicable standard for impaired-driving blood testing, are separate questions with separate answers.
• What happened before the analysis. Often the most productive area and the most overlooked. The collection tube and its preservative, storage temperature, the time between draw and analysis, and the stability of the particular drug in stored blood all bear on what the number means.

The concentration reported then has to be evaluated against the therapeutic range for the specific drug, the defendant’s dosing history and tolerance, and the timing of the draw relative to the last dose and to the time of driving.

No Legal Limit for Prescription Drugs in Texas

Texas has a per se BAC limit of 0.08 for alcohol. There is no equivalent per se limit for any prescription medication. The prosecution cannot point to a number and say the defendant was over the limit. It has to prove actual loss of normal mental or physical faculties. That higher evidentiary burden, compared with an alcohol case where a result of 0.08 or more satisfies the definition of intoxication on its own under §49.01(2)(B), is one of the reasons prescription drug DWI cases are often more defensible.

The Penalties Are the Same as an Alcohol DWI

Nothing about the punishment range softens because the intoxicant came from a pharmacy. A prescription DWI is charged and punished exactly like an alcohol DWI.

• First offense: Class B misdemeanor. A minimum of 72 hours of confinement, up to 180 days in county jail, and a fine of up to $2,000 under Penal Code §49.04(b). Community supervision is typically granted to first offenders.
• The 0.15 enhancement usually has nothing to attach to. A Class B DWI is enhanced to a Class A when it is shown the accused had an alcohol concentration of 0.15 or greater at the time of testing. There is no drug equivalent, so in a pure prescription-medication case with no alcohol there is nothing to trigger the enhancement.
• One enhancement does apply, and it is new. Since September 1, 2025, DWI committed in a school crossing zone during the hours the reduced speed limit applies is a state jail felony under §49.04(e). It is a first-offense felony keyed purely to location, and it applies whatever the intoxicant was.
• Repeat offenses escalate on the same ladder. A second offense is a Class A misdemeanor with a 30-day minimum term of confinement, and a third is a third-degree felony, under the same enhancement scheme that applies to alcohol DWI. Prior DWI convictions count no matter what the intoxicant was, in either direction.
• Deferred adjudication is often available, and more available than in an alcohol case. Deferred adjudication has been available for DWI offenses committed on or after September 1, 2019. It is off the table if, at the time of the offense, the driver held a commercial driver’s license or commercial learner’s permit, or had an alcohol concentration of 0.15 or higher; and it is unavailable where punishment may be increased because of a prior conviction, or where the charge is DWI with a child passenger, intoxication assault or intoxication manslaughter. In a prescription-medication case with no alcohol, the 0.15 bar cannot apply, which can leave deferred open where it would be closed in an alcohol case. It is deferred in name only in one important respect: §49.09(g) treats it as a conviction for enhancing a later DWI.
• A commercial license is its own problem. A prescription DWI disqualifies a commercial driver the same way an alcohol DWI does, and in a commercial vehicle the mere presence of a controlled substance or drug in the body is a disqualifying event without any finding of impairment. Combined with the deferred adjudication bar above, a CDL holder facing a prescription DWI has both the worst exposure and the fewest options.

Clearing the Record After a Prescription DWI

A DWI conviction cannot be expunged in Texas once it is final. Expunction destroys records and is reserved for cases that ended in acquittal or dismissal. But sealing is a different remedy, and there is a feature of the sealing statutes that favors prescription drug defendants specifically.

The DWI nondisclosure statutes exclude anyone whose offense was punishable under §49.04(d), the 0.15 enhancement, and that subsection keys to an “alcohol concentration”. In a prescription-drug-only case there is no alcohol concentration to show, so the exclusion cannot be triggered regardless of the drug levels in the report. Which statute applies depends on how the case resolved:

• Community supervision after conviction. Government Code §411.0731. Two years after completing supervision if an ignition interlock was a condition for at least six months, five years if it was not.
• A sentence served rather than probation. Government Code §411.0736. Three years after completing the sentence with the same six-month interlock condition, five years without it.
• DWI deferred adjudication. Government Code §411.0726. Two years after the supervision is completed and the case is discharged and dismissed, with no interlock condition required.

Now the trap, which matters more in a prescription case than anywhere else. The short two and three year tracks are only available where an ignition interlock was ordered for at least six months. In a case with no alcohol in it, a court often sees no reason to order an interlock, and the client walks out of the courtroom relieved and quietly consigned to the five-year track. If sealing matters to you, that is a condition to discuss before the plea, not after. It is one of the few places in a DWI case where asking for a restriction is the better outcome.

Two further gates apply. The State can defeat the petition by showing the offense involved a motor vehicle collision with another person, including a passenger in your own car. And the applicant must have no prior conviction or deferred adjudication for anything other than a fine-only traffic offense. An order of nondisclosure is not erasure, since law enforcement and a defined list of licensing agencies can still see the record, but it removes the conviction from the background checks most employers and landlords run.

The Bottom Line

Texas DWI law reaches prescription medication. “It was prescribed” is not a complete defense, and a valid prescription does not exempt a driver from prosecution if the State alleges the medication caused loss of faculties. Older adults, patients on multiple medications, and patients on common sedating drugs are at particular risk. The defense to a prescription DWI case is not the prescription itself. It is a forensic, pharmacological and medical analysis of whether the State can actually prove the connection between the drug present and the alleged impairment. And if a case does end in a conviction, the sealing analysis is often better in a drug case than in an alcohol case, so long as the interlock condition is handled at the right moment. That work requires a defense lawyer who understands both the law and the science. For how the State builds any drug case, see how Texas police prove a drug DWI; for where this charge sits on the ladder, see Texas DWI charges.

Frequently Asked Questions

Can you get a DWI in Texas for prescription medication? Yes. Texas has no separate drugged-driving statute, so driving under the influence of a prescription drug is charged as DWI under Penal Code §49.04 whenever the medication causes the loss of normal mental or physical faculties. It does not matter that the drug was lawfully prescribed and lawfully taken.

Is a valid prescription a defense to a Texas DWI? No. Penal Code §49.10 states that being entitled to use a substance is not a defense to an intoxication offense. A prescription explains why the drug is in your system, and it can matter a great deal to how a prosecutor or a jury views the case, but it does not defeat the charge on its own.

Does staying within my prescribed dose protect me? Not by itself. Texas asks whether you lost the normal use of your faculties, not whether you exceeded a dosage, so taking a medication exactly as directed is not a defense if the State can show impairment. It is still worth establishing, because it goes to how and why you were taking the drug.

Does a positive blood test prove I was impaired? No. A toxicology result establishes presence, not impairment. Separating the two is the central question in a prescription drug DWI, because many medications remain detectable long after any effect on driving has passed.

Can I argue that nobody warned me the medication would impair me? You can put that fact in front of a jury, but not under the name involuntary intoxication, which Texas courts have held is not a defense to DWI. The theory that does exist is the involuntary act, and the Court of Criminal Appeals has drawn it narrowly: taking your own medication by mistake is still a voluntary act. It reaches the case where someone else caused you to ingest the substance.

Will I lose my license if my blood shows only prescription drugs? Not from the test itself, if you consented. The failure-based administrative suspension requires an alcohol concentration of 0.08 or more, so drug results alone do not trigger it. A refusal is different, and any detectable alcohol suspends a driver under 21. A later conviction carries its own suspension in any event.

Are the penalties lower because it was a prescription? No. A first prescription DWI is a Class B misdemeanor with the same 72-hour minimum, the same 180-day maximum, and the same $2,000 fine ceiling as a first alcohol DWI. The one practical difference runs in the defendant’s favor: with no alcohol concentration in the case, the 0.15 bar to deferred adjudication does not apply.

Can a prescription DWI conviction be sealed? Often, yes, and more readily than an alcohol case, because the 0.15 exclusion in the nondisclosure statutes keys to alcohol concentration. The waiting period depends on whether the case ended in probation, a sentence, or deferred adjudication, and on whether an ignition interlock was ordered as a condition for at least six months.

Prescription DWI Defense at Deandra Grant Law

Deandra Grant Law defends DWI and intoxication-offense cases across North and Central Texas including Dallas, Fort Worth, Plano, McKinney, Frisco, Allen, Lewisville, Denton, Rockwall, and Waco. We handle prescription DWI cases with the forensic and pharmacological depth they require: reviewing medical records, analyzing blood toxicology results, consulting with toxicology experts, and challenging the State’s connection between the medication and the alleged impairment. Our team includes an ACS-CHAL Forensic Lawyer-Scientist with a Master of Science in Pharmaceutical Science and a Graduate Certificate in Forensic Toxicology.

If you have been charged with DWI in Texas based on prescription medication, call Deandra Grant Law at (214) 225-7117 or visit texasdwisite.com to schedule a confidential consultation. And remember that the 15-day ALR deadline runs from the date of service of the notice of suspension.

Have a DWI question you want answered in this series? Submit it at texasdwisite.com and you might see it featured in a future Ask Deandra post.